Intends to develop a mobile app approved medical device which will target paediatric clinicians in the NHS and private practice that need to make complex drug dose calculations.

Summary

Remedy Medpass Ltd is developing mobile-based software that will be sold to customers on an annual subscription model. The product will target paediatric clinicians that are required to make complex drug dose calculations to administer to children, which can be a protracted and difficult process to complete under the pressure of a clinical working environment. It is envisaged that the product may help reduce the risks associated with both over and under-prescribing drugs in young children.

Product

Life Sciences SEIS

Sector

Medical Technology

Status

Closed

HMRC

Advanced Assurance